中国市場銘柄情報

600222 Henan Taloph Pharmaceutical Stock

銘柄追加

5.06
+0.05+1.00%

取引中 04/29 13:44 CST

29.04億時価総額47.29直近PER

Henan Taloph Pharmaceutical Stockに関するコメント

ログインコメントを投稿

Moomoo AI

02/06 07:35

Market expectations of a decline in Henan Taloph Pharmaceutical's revenue performance and slower growth compared to the industry average may contribute to its low P/S ratio. Shareholders' wariness of the company's ability to keep up with industry growth could be a factor in the declining share price.

Why Investors Shouldn't Be Surprised By Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) 30% Share Price Plunge

Moomoo AI

2023/10/31 08:13

Henan Taloph's lower P/S ratio may be justified due to slower growth rates than industry rivals. Doubts about the company's ability to maintain robust growth in line with industry may hinder share price recovery.

Little Excitement Around Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) Revenues

まだコメントはありません

分析

アナリスト評価

データなし

目標株価

データなし

ホット

中国A株

総合人気